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Abstract
Background:  In immunopathological diseases, such as multiple sclerosis (MS), genetic and
environmental factors that contribute to the initiation and progression of the disease are often
discussed. The Theiler murine encephalomyelitis virus-induced demyelination disease (TMEV-IDD)
model used to study MS reflects this: genetically susceptible mice infected intra-cerebrally with
TMEV develop a chronic demyelination disease. TMEV-IDD can be induced in resistant mouse
strains by inducing innate immunity with lipopolysaccharide (LPS). Interestingly, Toll-like receptor
4 (TLR4) is the cognate receptor for LPS and its activation can induces up-regulation of other TLRs,
such as TLR7 (the receptor for TMEV) and 9, known to be involved in autoimmunity. Up-regulation
of TLRs could be involved in precipitating an autoimmune susceptible state. Consequently, we
looked at TLR expression in the susceptible (SJL/J) and resistant (C57BL/6) strains of mice infected
with TMEV. The resistant mice were induced to develop TMEV-IDD by two LPS injections
following TMEV infection.
Results: Both strains were found to up-regulate multiple TLRs (TLR2, 7 and 9) following the TMEV
infection. Expression of these TLRs and of viral mRNA was significantly greater in infected SJL/J
mice. The susceptible SJL/J mice showed up-regulation of TLR3, 6 and 8, which was not seen in
C57BL/6 mice.
Conclusion: Expression of TLRs by susceptible mice and the up-regulation of the TLRs in resistant
mice could participate in priming the mice toward an autoimmune state and develop TMEV-IDD.
This could have implications on therapies that target TLRs to prevent the emergence of conditions
such as MS in patients at risk for the disease.
Background
It is now widely accepted that the central nervous system
(CNS) contains its own immune system to protect it from
infection and to repair injury. At the core of this response
are the microglia, which play the role of macrophages in
the CNS. Through the Toll-like Receptor (TLR) family of
receptors, microglia are able to recognize pathogen-asso-
ciated molecular patterns, thereby initiating innate immu-
nity in the brain. Once activated, innate immunity can
mobilize the microglia, as well as invading macrophages
from the periphery, to clear pathogens and debris from
the CNS. This response also serves as a bridge to orches-
trate adaptive immunity if needed. Nevertheless, an
immune response in the CNS can have drastic conse-
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quences if left unchecked. For example, by having other
immune cells invade the CNS, including T-cells, the risk of
developing an immune response against self-antigens has
to be considered. Such a case is believed to exist in multi-
ple sclerosis (MS), whereby antibodies are generated
against myelin proteins, leading to the destruction of the
myelin sheath of neurons and the associated neurological
dysfunctions.
The concept of autoimmunity in MS has been extensively
explored by various animal models. One of the most com-
mon is experimental autoimmune encephalomyelitis
(EAE), where an adjuvant is given with myelin protein in
order to incite a self-response to myelin in the rodent.
Another model that is gaining importance is the Theiler
murine encephalomyelitis virus-induced demyelination
disease (TMEV-IDD) model of MS. In this model, suscep-
tible (SJL/J, for example) mice are infected intracerebrally
with the TMEV and, following encephalitis and a latency
phase, they develop the chronic on-going TMEV-IDD,
with recurring demyelination and associated motor defi-
cits. In resistant mouse stains, the initial encephalitis
occurs, but no TMEV-IDD persists. However, if innate
immunity is stimulated in resistant mice through the sys-
temic administration of lipopolysaccharide (LPS), a lig-
and for the TLR4 receptor, susceptibility and clinical
symptoms associated with TMEV-IDD are increased[1].
Interestingly, the single stranded RNA genome of TMEV is
believed to bind to TLR7 and its double stranded replica-
tion intermediate to TLR3 located the endosomes and lys-
osomes of host cells[2]. Since LPS is known to up-regulate
multiple TLRs in the CNS's microglia and invading mac-
rophage[3,4], this could be at the source of the enhanced
susceptibility of LPS-treated mice infected with TMEV.
Indeed, TLR4-dependent activation of innate immunity
has been suggested to be involved in infection-induced
immune diseases[5]. In addition to the recent reports that
TLRs can bind endogenous molecules[6], it becomes
imperative to characterize the TLR profile in the CNS of
TMEV-IDD susceptible and resistant strands of mice fol-
lowing infection with the virus.
In this study, the TLR mRNA expression profiles of the
TMEV-IDD susceptible SJL/J and resistant C57BL/6 mice
were determined by in situ hybridization a month follow-
ing TMEV infection. The C57BL/6 mice were treated with
LPS in order to promote the chronic infection and demy-
elination state. By comparing the TLR expression profile
of TMEV-IDD resistant and susceptible mouse strains,
insight about potential TLRs involved in the pathogenesis
of TMEV-IDD could be revealed.
Methods
C57BL/6 and SJL/J mice
Adult (8 week old) male (25–35 g) C57BL/6 (n = 30) and
SJL/J (n = 15) mice were originally purchased from
Charles Rivers Canada, St. Constant, QC, Canada. The
C57BL/6 mice are known to be resistant to the TMEV,
while the SJL/J mice are susceptible to chronic TMEV
infection[7]. All animals were acclimated to standard lab-
oratory conditions (14-h light, 10-h dark cycle; lights on
at 06:00 and off at 20:00 h) with free access to rodent
chow and water for a week. All protocols were conducted
according to the Canadian Council on Animal Care guide-
lines, as administered by the Laval University Animal Wel-
fare Committee.
Theiler's Murine encephalomyelitis virus preparation and 
intracerebral injection
The plasmid containing the Daniel strain of TMEV was a
generous gift from T. Michiels (Université Catholique de
Louvain, Brussels, Belgium). The plasmid was replicated,
purified and transferred by electroporesis into adherent
BHK-21 cells. Viral concentration was determined as
plaque forming units (pfu) on cultures of the same strain.
The mice were anesthetized and injected intracerebrally
with 2 × 105 pfu of TMEV or vehicle saline with the use of
a sterile syringe fitted with a William's collar. The injec-
tion is made halfway between the back of the eye and the
ear, at a 45 degree angle from the top of the skull. Infec-
tion was confirmed by in situ hybridization for RNA cod-
ing for viral protein (see below). To increase sensitivity of
the C57BL/6 to the TMEV, the protocol of Kim and col-
leagues[1] was followed: two injections of LPS (20 μg/0.1
ml, i.p., Sigma Aldrich) in sterile saline were given day 0
and +5 post-infection with the virus. Mice were sacrificed
30 days following the infection with the TMEV, when the
infection and demyelination is thought to be well estab-
lished (see Fig. 1).
To collect the brain and spinal cord tissues, the mice were
deeply anesthetized via an i.p. injection of a mixture of
ketamine hydrochloride and xylazine, and then rapidly
perfused transcardially with 0.9% saline, followed by 4%
paraformaldehyde/3.8% Borax in sodium phosphate
buffer (pH 9 at 4°C). The brains and spinal cords were
rapidly removed, post-fixed overnight and then placed in
a solution containing 10% sucrose diluted in 4% parafor-
maldehyde/3.8% Borax buffer (pH 9) overnight at 4°C.
The brains were mounted on a microtome (Reichert-Jung,
Cambridge Instruments Company, Deerfield, IL, USA),
frozen with dry ice, and cut into 25 μm coronal sections
from the olfactory bulb to the end of the medulla. Repre-
sentative 2 mm segments from the cervical, thoracic and
lombosacral regions of the spinal cord were collected in
20 μm thick coronal sections. The slices were collected in
a cold cryoprotectant solution (0.05 M sodium phosphate
buffer, pH 7.3, 30% ethylene glycol, 20% glycerol) and
stored at -20°C.Virology Journal 2008, 5:154 http://www.virologyj.com/content/5/1/154
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Viral RNA and TLR mRNA expression and demyelination 
analysis using in situ hybridization
In order to detect the TMEV, a cDNA probe was generated
against the VP1 viral protein coding region of the TMEV.
Furthermore, the expression of TLRs binding specific viral
(TLR3, TLR7, and TLR8) and bacterial (TLR2, TLR4, and
TLR6) elements (TLR9 recognizes unmethylated CpG ele-
ments in both viral and bacterial DNA) was done using
cDNA probes against their respective mRNA. All cDNA
probes were generated by PCR amplification. In situ
hybridization (ISH) was performed on every 12th section
of the collected brain and spinal cord tissue using 35S-
labeled cRNA probes as described previously [8-10].
Theiler's murine encephalomyelitis virus infection can be established in resistant C57BL/6 mice following lipopolysaccharide  intraperitoneal injections Figure 1
Theiler's murine encephalomyelitis virus infection can be established in resistant C57BL/6 mice following 
lipopolysaccharide intraperitoneal injections. Photomicrographs of X-ray films from in situ hybridization (ISH) signals for 
viral protein 1 (VP1) RNA expression in the brain and spinal cord of SJL/J and C57BL/6 mice one month following Theiler's 
murine encephalomyelitis virus (TMEV) infection (intracerebral, 2 × 105 p.f.u.). In order to render the C57BL/6 susceptible to 
TMEV, LPS injections (20 μg, i.p., Sigma Aldrich) were given immediately following the TMEV injection and +5 days post-infec-
tion. A majority of the C57BL/6 mice receiving the (lipopolysaccharide) LPS (6/10) developed a TMEV infection (as shown by 
the expression of VP1, above) while one mouse (1/10) not receiving the LPS developed a lasting infection (not shown). Inset 
(top): dark field photomicrography of proteolipid protein (PLP) mRNA expression following ISH. Hybridized slides were 
dipped into NTB emulsion milk (Kodak). All SJL/J and C57BL/6 mice that developed an infection showed demyelination, as 
exemplified by the absence of PLP expression in white mater areas of the spinal cord (dashed line area). Bottom panel shows 
quantitative analysis of VP1 optical density (O.D.) in representative spinal cord sections. Although comparisons revealed that 
VP1 expression was significantly lower in infected C57BL/6 versus SJL/J mice, VP1 expression in C57BL/6 was still significantly 
higher in the TMEV infected versus vehicle saline group. Data presented as mean ± SEM. †: significant SJL/J vs C57/BL6 pair wise 
comparison within TMEV treatment, Bonferonni corrected t-test p < 0.05; *: significant TMEV vs Vehicle within strain pair wise 
comparison Bonferonni corrected t-test p < 0.05.Virology Journal 2008, 5:154 http://www.virologyj.com/content/5/1/154
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In order to visualize the demyelination done by the
TMEV, ISH was done on the tissue for PLP as described
above. The lack of PLP expression is a reliable measure of
demyelination in other models of CNS damage used pre-
viously[11].
Co-localization of TMEV RNA within neuronal cell types 
using a combination of immunocytochemistry with in situ 
hybridization
Immunocytochemistry (IC) was combined with the ISH
protocol to determine whether viral RNA was expressed in
microglia, astrocytes, oligodendrocytes, neurons, and T-
cells in the infected mice. Immunocytochemistry against
anti-ionized calcium binding adapter molecule 1 (iba1,
Wako Chemicals, Richmond VA, labeling infiltrating mac-
rophages and microglia), glial fibrillary acidic protein
(GFAP, Chemicon International, Temicula, CA, labeling
astrocytes), Neuronal Nuclei (NeuN, Chemicon Interna-
tional, labeling neurons), carbonic anhydrase II (CAII, a
generous gift from Dr. S. Ghandour, Université Louis Pas-
teur, Strasbourg, France, labeling oligodendrocytes) and
T-cell receptor alpha beta (TCRαβ, Cedar Lane Laborato-
ries, Burlington, ON, Canada, labeling most T-cells) was
followed by ISH (TLR2 mRNA) as described previ-
ously[12].
Data analysis
The relative intensity of mRNA signals was measured on
Biomax MR X-ray films (Kodak, Rochester, NY, USA).
Transmittance values (referred to in this study as O.D.) of
positive hybridization signal were measured under a
Northern Light desktop illuminator (Imaging Research,
Ste-Catherine's, ON, Canada) using a Sony camera video
system attached to a MicroNikkor 55-mm Vivitar exten-
sion tube set for a Nikon lens and coupled to a Dimension
GX270 personal computer (Dell Computers, North York,
ON, Canada)) and ImageJ software (version 1.23, W. Ras-
band, National Institute of Health, Bethesda, MD, USA).
O.D. for each pixel was calculated using a known standard
of intensity and distance measurements from a logarith-
mic specter adapted from BioImage Visage 110 s (Milli-
pore, Ann Arbor, MI, USA). Eight spinal cord sections
from experimental animals were digitized and subjected
to densitometric analysis, yielding average peak O.D.'s.
The O.D. for each section was corrected for the average
background signal on the film. To standardize the sam-
pling procedure, the 8 sections showing the strongest sig-
nal were analyzed and averaged.
Statistical analysis
Data were compiled and the statistical analysis was per-
formed using SigmaStat (Systat, San Jose, CA) software
(version 3.5), with TMEV vs. saline treatment, and SJL/J
vs. C57BL/6 strain differences as independent variables.
Between-group differences of RNA expression density
were analyzed using analysis of variance (ANOVA). All
pair wise multiple comparison procedures were con-
ducted using Bonferroni corrected t-tests. An alpha < 0.05
was considered significant.
Results
TMEV infection of susceptible SJL/J versus resistant C57BL/
6 mice
All of the SJL/J mice injected with the TMEV (7/7) devel-
oped a sustained, chronic infection through the month
following the intracerebral injection of TMEV. This was
exemplified by showing a strong expression of TMEV VP1
protein in their hindbrain and the spinal cord (Fig 1.). The
presence of TMEV in the CNS engendered a strong gliosis
at the sites of infection (Fig. 2a). With a combination of
ISH for VP1 and IC, the cellular loci of infection for the
TMEV were revealed to include Iba+ infiltrating macro-
phage/microglial cells, GFAP+ astrocytes, NeuN+ neurons
and CAII+ oligodendrocytes (Fig. 2b). Although TCRαβ+ T-
cells were found close to areas of infection, they did not
co-localize with VP1 RNA.
The C57BL/6 mice showed much greater susceptibility to
the TMEV when receiving the LPS injection regimen (6/10
infected) than only saline injections (1/10 infected). For
the sake of consistency, only the C57BL/6 mice on the LPS
regimen were included in the study. Comparing VP1
expression, a significant difference was found between
SJL/J and C57BL/6 mice (Fig. 1, p < 0.05, F(1,25) = 25.85)
and TMEV versus vehicle treated mice (p < 0.05, F(1,25) =
106.417), as well as a significant treatment × strain inter-
action (p < 0.05, F(1,25) = 28.361). Pair wise comparison
revealed significant VP1 expression differences between
TMEV and vehicle groups of SJL/J (Bonferroni t-test, p <
0.05, t = 9.768) and C57BL/6 (Bonferroni t-test, p < 0.05,
t = 4.165) mice. Furthermore, the infected SJL/J mice
showed a significantly higher VP1 expression than their
infected C57BL/6 counterparts (Bonferroni t-test, p <
0.05, t = 8.063). However, the demyelination seen in the
white mater of spinal cord sections of the two stains was
roughly the same (see Figure 1, inset). These results sup-
port previous work showing that chronic TMEV-IDD can
be attained in the resistant C57BL/6 strain following LPS
treatment. However, this infection is not as severe as in
the susceptible SJL/J strain.
Expression of viral component-specific TLRs in TMEV 
infected SJL/J and C57BL/6 mice
The members of TLR receptor family are known for their
specificity to bind particular components of infectious
agents. In this case, TLR7 specifically recognizes the viral
single stranded RNA from TMEV (TLR8 also recognizes
ssRNA, but is not thought to be involved in TMEV bind-
ing), while TLR3 recognizes its double stranded form that
appears during replication. Accordingly, TLR7 expressionVirology Journal 2008, 5:154 http://www.virologyj.com/content/5/1/154
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was found to be significantly upregulated in TMEV
infected SJL/J and C57BL/6 mice compared to controls
(Fig. 3, p < 0.05, F(1,25) = 9.077, no pair wise comparison
was done because there was no strain × treatment interac-
tion, p = 0.404, F(1,25) = 0.723). However, TLR3 was found
significantly upregulated in SJL/J (Bonferroni t-test, p <
0.05, t = 6.358), but its expression in C57BL/6 was not sig-
nificantly increased by TMEV infection (Bonferroni t-test,
p = 0.431, t = 0.802). TLR8 was also found to be upregu-
lated in SJL/J infected mice (Bonferroni t-test, p < 0.05, t =
3.256), but not in C57BL/6 (Bonferroni t-test, p = 0.973,
t = 0.0340), while TLR9, which recognizes unmethylated
CpG motifs in viral and microbial DNA, was found to be
significantly upregulated in SJL/J (Bonferroni t-test, p <
0.05, t = 6.308) and to a lesser extent in C57BL/6 (Bonfer-
roni t-test, p < 0.05, t = 2.576). This TLR expression profile
would seem to indicate that TMEV expression can lead to
a wide-spread up-regulation of viral component-specific
TLRs in the brain, irrespective whether or not they can
bind elements of the TMEV. Our results show this is more
obvious in a TMEV-susceptible versus  a TMEV-resistant
mouse strain.
Expression of bacterial component-specific TLRs in TMEV 
infected SJL/J and C57BL/6 mice
The TMEV-infected mice also show an up-regulation in
bacteria-associated TLR mRNA. Both strains exhibit an
increase in TLR2 expression (Fig. 4, p < 0.05, F(1,25) =
23.492, no pair wise comparison was done because there
was no strain × treatment interaction, p = 0.084, F(1,25) =
3.284). Although TLR2 is the main receptor for compo-
nents of the cell wall of Gram positive bacteria, its expres-
sion is also associated with microglial activation. The
TLR6 mRNA expression was only upregulated by the
TMEV infection in SJL/J (Bonferroni t-test, p < 0.05, t =
4.224). The Gram negative bacteria-associated TLR4
showed visually but insignificant increases in expression
(p = 0.074, F(1,25) = 3.529). TLR4 is recognized as being
expressed constitutively and not regulated even by its own
ligand, LPS.
Discussion
To establish a persistent autoimmune state of demyelina-
tion in the mouse, the TMEV infection must involve a
multitude of viral-host interactions that increase the reac-
Viral protein expression in microglia, astrocytes, oligodendrocytes and neurons in the spinal cord of TMEV-infected mice Figure 2
Viral protein expression in microglia, astrocytes, oligodendrocytes and neurons in the spinal cord of TMEV-
infected mice. A. Left panes shows microgliosis and astrogliosis (immunocytochemistry, brown cells, red surrounded areas) 
at sites where viral protein VP1 expression (in situ hybridization, silver grains) was present, while right panes shows Iba+ micro-
glia and GFAP+ astrocytes co-localized with VP1 hybridization (orange arrow, higher magnification in inset) B. VP1 expression 
was also found to co-localize with CAII+ oligodendrocytes (top, green arrows) and NeuN+ neurons (bottom, green arrow). 
Expression of VP1 was not found to occur in TCRαβ-positive T-cells (not shown). In all instances VP1 expression could be 
found outside of the cell type assayed. Scale bars: green = 5 μm, red = 25 μm.Virology Journal 2008, 5:154 http://www.virologyj.com/content/5/1/154
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Expression of Toll-like receptors for viral elements in the central nervous system of SJL/J and C57BL/6 mice after infection with  Theiler's murine encephalomyelitis virus Figure 3
Expression of Toll-like receptors for viral elements in the central nervous system of SJL/J and C57BL/6 mice 
after infection with Theiler's murine encephalomyelitis virus. C57BL/6 mice were further treated twice with lipopoly-
saccharide to increased susceptibility to Theiler's murine encephalomyelitis virus (TMEV). The coronal sections (25 mm) we 
taken from X-ray films (Biomax, Kodak, exposed 3 days) and are representative hybridization signals for Toll-like receptors 
(TLR) TLR3, TLR7, TLR8 and TLR9 near the level of injection (cortical slices) and in the spinal cord. Bottom panel shows quan-
titative analysis of TLRs signal optical density (O.D.) in representative spinal cord sections. Although comparisons revealed that 
TLR expression was significantly lower in infected C57BL/6 versus SJL/J mice (except TLR7), TLR expression in C57BL/6 was 
still significantly higher in the TMEV infected versus vehicle saline group for TLR7 and TLR9. Data presented as mean ± SEM. **: 
ANOVA significant main effect of TMEV vs Vehicle, p < 0.05; *: significant TMEV vs Vehicle pair wise comparison within strain, 
Bonferonni corrected t-test p < 0.05; †: significant SJL/J vs C57/BL6 pair wise comparison within TMEV treatment, Bonferonni 
corrected t-test p < 0.05.Virology Journal 2008, 5:154 http://www.virologyj.com/content/5/1/154
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tivity of the host immune system in the CNS to the point
that a host response to myelin elements occurs. It is well
established that TLRs recognize components of viruses
and are involved with the initiation of the first line of
defense against foreign particles. It is now emerging that
TLRs can also recognize and bind endogenous proteins,
and their presence (or absence) is discussed and often
implicated in various model of immune diseases such as
lupus, arthritis and MS (see Ehlers and Ravetch[13] and
Papadimitraki, Bertsias and Boumpas[6] for reviews). The
implication of TLRs in the genesis of TMEV-IDD seems
even more relevant when it comes to establishing this
model in the resistant C57BL/6 mice, where LPS treat-
ment, a TLR4 ligand, is needed to stimulate the chronic
autoimmune state in the mice. The endotoxin LPS is
known to up-regulate multiple TLRs in the mouse brain
and in TMEV-infected microglia[3,4]. This could support
the direct or indirect (by the induction of cytokines and
chemokines) involvement of TLRs in the initiation of
TMEV-IDD in C57BL/6 resistant mice following LPS stim-
ulation.
The involvement of TLRs in the TMEV-IDD is well sup-
ported by the results of the current experiments: multiple
TLRs are up-regulated by the TMEV in susceptible SJL/J as
well as in the resistant C57BL/6 treated with LPS. These
TLRs include TLR7, the cognate receptor for TMEV, TLR9,
and TLR2. The infected SJL/J mice also show a significant
up regulation of TLR3, TLR6 and TLR8. The expression of
these receptors is observed in C57BL/6, but does not reach
significance. The expression of TLR4 is seen in both
strains, but does not reach significance due to higher base-
line expression and variability. A similar expression of
TLRs upregulated by TMEV was reported earlier, but
focused on the in vitro induction by TMEV in cultured
microglia[4]. The use of our in vivo approach permits us to
observe the co-localization of the TLR expression to the
specific areas of the CNS where the TMEV was detected.
This method also confirms that the TMEV is able to infect
all of the local cell populations of the CNS. Yamada and
colleagues had previously reported similar spatial and
temporal viral distribution[14].
Both the susceptible strain and the resistant stain stimu-
lated with LPS are able to up-regulate TLRs following
TMEV-IDD, with obvious differences, namely the inten-
sity of the TLR expression and the lack of significant TLR3,
6 and 8 up-regulation in C57BL/6 mice. TLR6 and 8 are
not commonly associated with autoimmune or demyeli-
nating processes, so their presence in the SJL/J mice could
be a simple consequence of the greater immune response
taking place in the SJL/J. On the other end, the absence of
a significant TLR3 upregulation and low TLR7 and 9 up-
regulation compared to the susceptible mice the infection
could hint at a possible mechanism by which LPS could
enhance their response to the TMEV. The expression of
these TLRs is in CNS regions where TMEV abounds, thus
it could reflect the higher viral titer in the SJL/J mice. That
would appear to be central in the enhanced response by
the susceptible mice is the intensity of the TLR signal. By
having a higher number of TLRs on the surface and inside
the endosomes and lysosomes of the immune cells, it
could increase their susceptibility to inadvertently recog-
nize self antigens and precipitate an autoimmune reac-
tion. The chance of an autoimmune response could be
potentiated by any cell death (oligodendrocytes, neurons,
microglia, etc.) occurring at the loci of infection and
demyelination. The nucleotides released by the dying cells
could bind the nucleotide-specific TLRs (TLR3, 7 and 9)
and trigger a self response. Even if these receptors are
located in the endosomes and are hard to reach, this has
already been discussed for other autoimmune diseases
such as lupus[15] and could also be at the root of the
importance of the LPS stimulation in the resistant mice.
This phenomenon especially pertains to plasmacytoid
dendritic cells (pDCs) that could make their way into the
CNS from the periphery. This specific class of dendritic
cell expresses high levels TLR3, TLR7 and TLR9, which
were all upregulated in the CNS of the TMEV-infected sus-
ceptible mice (for review, see Gilliet et al[16]). A possible
mechanism by which the pDCs could be involved in
autoimmune process is the recognition of self DNA (from
dying cells) aggregates by TLR9. These aggregates are pos-
sible through the interaction of self DNA and high-mobil-
ity group box 1 protein with LL37 (both released from
dying cells). This complex could be delivered by lipid rafts
or TLR9-containing endosomes in pDCs and trigger an
autoimmune response[16]. Although the expression of
TLR3, 7 and 9 is lower in the resistant C57BL/6 mice, LPS
is known to up-regulate their expression in immune cells
[4,17]. Even if this up-regulation is transient, and thus not
detected several weeks after in LPS injection in the resist-
ant mice, it could be enough to activate peripheral macro-
phages and pDCs and precipitate the autoimmune
phenomenon described above. This early activation by
LPS could compensate for a weaker response of the pDCs
in the resistant strain of mice. Interestingly, pDCs are one
of the main therapeutic targets for MS[16], and thus the
involvement of TLRs in the processing of self-DNA in
these cells could be a major player in the treatment of the
disease.
The mechanism by which TLRs could play a role in
autoimmunity is still debated. Some have suggested that
Th1-mediated autoimmunity could be mediated through
MyD88 activation, a common signal transduction protein
used by most TLRs[18]. Furthermore, TLR9 and MyD88
signaling have been linked to class switching to patho-
genic IgG2a and 2b auto-antibodies in lupus[19]. Thus,
modulation of that action of TLRs and MyD88 could pro-Virology Journal 2008, 5:154 http://www.virologyj.com/content/5/1/154
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Expression of Toll-like receptors for bacterial elements in the central nervous system of SJL/J and C57BL/6 mice after infection  with Theiler's murine encephalomyelitis virus Figure 4
Expression of Toll-like receptors for bacterial elements in the central nervous system of SJL/J and C57BL/6 
mice after infection with Theiler's murine encephalomyelitis virus. C57BL/6 mice were further treated twice with 
lipopolysaccharide to increased susceptibility to Theiler's murine encephalomyelitis virus (TMEV). The coronal sections (25 
mm) we taken from X-ray films (Biomax, Kodak, exposed 3 days) and are representative hybridization signals for Toll-like 
receptors (TLR) TLR2, TLR4 and TLR6 near the level of injection (cortical slices) and in the spinal cord. Please note the con-
cordant expression all of the TLRs in areas similar to VP1 expression (see Fig 1) in SJL/J mice. Bottom panel shows quantitative 
analysis of TLRs signal optical density (O.D.) in representative spinal cord sections. TLR2 and TLR6 were found to be signifi-
cantly expressed in infected SJL/J mice, while TLR4 expression was noted but did not reach significance. TLR2 was the only 
TLR expression to reach significance in infected C57BL/6. Vehicle injection had no effect on TLR expression. Data presented as 
mean ± SEM. **: ANOVA significant main effect of TMEV vs Vehicle, p < 0.05; *: significant TMEV vs Vehicle pair wise compar-
ison within strain, Bonferonni corrected t-test p < 0.05; ††: ANOVA significant main effect of SJL/J vs C57BL/6, p < 0.05; †: sig-
nificant SJL/J vs C57/BL6 pair wise comparison within TMEV treatment, Bonferonni corrected t-test p < 0.05.Publish with BioMed Central    and   every 
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vide potential therapeutic targets for the treatment of
immune disorders. Early warning signs of immune disor-
ders could also be deciphered by looking at the reactivity
of the signaling through TLRs, which could open the door
to detecting such disorders promptly and optimizing their
treatment at an earlier phase in their development.
Conclusion
This study clearly describes the presence of multiple TLRs
in the brain of mice during TMEV-IDD. These include
TLRs involved in the recognition of the viral genome
(TLR3 and TLR7) and multiple other TLRs that could be
involved in autoimmune processes. The direct link
between TLRs and the autoimmune and other mecha-
nisms involved in the establishment of the chronic dereg-
ulated immune state observed during TMEV-IDD remains
to be elucidated, but reinforces TLRs as possible culprits in
the initiation of self-immune processes in the brain. This
could encourage the investigation of TLRs as possible
therapeutic targets in autoimmune/demyelinating dis-
eases.
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